Bioengineered recombinant human BMP-2 (rhBMP-2) has been demonstrated to increase tumor growth of lung carcinoma(18), pancreatic carcinoma(13)and prostate cancers cells in the absence of androgen(19). Here, BMP2 is linked to prostate carcinoma.